While the use of artificial intelligence (AI) may improve clinical trial recruitment and inclusion, the technology also presents risks and challenges, including for privacy and informed consent, subject safety and potential bias, according to a new World Health Organization (WHO) report. The report – Benefits and Risks of Using Artificial Intelligence for Pharmaceutical Devel... Read More